Llwytho...
New Therapies in Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with high rates of mortality and morbidity. Beginning with cetuximab, investigators continue to optimize antibody technology to target cell surface receptors that promote HNSCC growth. Small molecules and oligonucleotides have also...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Trends Cancer |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226306/ https://ncbi.nlm.nih.gov/pubmed/29709262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2018.03.006 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|